190 related articles for article (PubMed ID: 34916042)
1. Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia?
Kreisler A; Djelad S; Simonin C; Baille G; Mutez E; Degardin A; Defebvre L; Labreuche J; Cailliau E; Duhamel A
Rev Neurol (Paris); 2022 Jun; 178(6):591-602. PubMed ID: 34916042
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
3. Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study).
Tyślerowicz M; Dulski J; Gawryluk J; Sławek J
Toxins (Basel); 2022 Sep; 14(10):. PubMed ID: 36287943
[TBL] [Abstract][Full Text] [Related]
4. Anatomy-guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement?
Kreisler A; Simonin C; Degardin A; Mutez E; Defebvre L
Eur J Neurol; 2020 Nov; 27(11):2142-2146. PubMed ID: 32579789
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type B for cervical dystonia.
Marques RE; Duarte GS; Rodrigues FB; Castelão M; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004315. PubMed ID: 27176573
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A therapy for cervical dystonia.
Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Duarte GS; Castelão M; Rodrigues FB; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004314. PubMed ID: 27782297
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A versus anticholinergics for cervical dystonia.
Rodrigues FB; Duarte GS; Castelão M; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD004312. PubMed ID: 33852744
[TBL] [Abstract][Full Text] [Related]
9. Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD).
Odorfer TM; Malzahn U; Matthies C; Heuschmann PU; Volkmann J
Neurol Res Pract; 2019; 1():2. PubMed ID: 33324868
[TBL] [Abstract][Full Text] [Related]
10. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
[TBL] [Abstract][Full Text] [Related]
11. A simplified ultrasonography-guided approach for neurotoxin injection into the obliquus capitis inferior muscle in spasmodic torticollis.
Walter U; Dudesek A; Fietzek UM
J Neural Transm (Vienna); 2018 Jul; 125(7):1037-1042. PubMed ID: 29488101
[TBL] [Abstract][Full Text] [Related]
12. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
Dressler D; Kupsch A; Seitzinger A; Paus S
Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
[TBL] [Abstract][Full Text] [Related]
13. Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement.
Schramm A; Bäumer T; Fietzek U; Heitmann S; Walter U; Jost WH
J Neural Transm (Vienna); 2015 Oct; 122(10):1457-63. PubMed ID: 25547861
[TBL] [Abstract][Full Text] [Related]
14. Headache attributed to craniocervical dystonia: A prospective cohort study.
Eugenio Ramalho Bezerra M; Sampaio Rocha-Filho PA
Eur J Pain; 2020 Sep; 24(8):1484-1494. PubMed ID: 32422691
[TBL] [Abstract][Full Text] [Related]
15. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry.
Trosch RM; Espay AJ; Truong D; Gil R; Singer C; LeWitt PA; Lew MF; Tagliati M; Adler CH; Chen JJ; Marchese D; Comella CL
J Neurol Sci; 2017 May; 376():84-90. PubMed ID: 28431634
[TBL] [Abstract][Full Text] [Related]
16. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of focal dystonia with botulinum toxin A].
Sojer M; Wissel J; Müller J; Poewe W
Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
Costa J; Borges A; Espírito-Santo C; Ferreira J; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004314. PubMed ID: 15674940
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
Figgitt DP; Noble S
Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
[TBL] [Abstract][Full Text] [Related]
20. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
Samotus O; Lee J; Jog M
J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
